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Abstract
Background: Millions of children worldwide suffer from posttraumatic stress disorder (PTSD) symptoms and other
mental health problems due to repeated exposure to war or organized violence. Forms of cognitive-behavioral
therapy (CBT) are the most commonly used treatment for PTSD and appear to be effective for children as well, but
little is known about the mechanisms of change through which they achieve their effectiveness. Here we present
the study protocol of a randomized controlled trial (RCT) studying the effectiveness and mechanisms of change of
Narrative Exposure Therapy (NET), a CBT-based, manualized, short-term intervention for PTSD symptoms resulting
from repeated traumatization, in immigrant children traumatized by war.
Methods/Design: We are conducting a multicentre, pragmatic RCT in a usual care setting. Up to 80 9–17-year-old
immigrant children who have experienced war and suffer from PTSD symptoms will be randomized into
intervention (NET) and control (treatment as usual, TAU) groups of equal sizes. The effectiveness of NET treatment
will be compared to both a waiting list and the parallel TAU positive control group, on the primary outcomes of
PTSD and depressive symptoms, psychological distress, resilience, and level of cognitive performance. The effects of
the intervention on traumatic memories and posttraumatic cognitions will be studied as potential mechanisms of
change mediating overall treatment effectiveness. The possible moderating effects of peritraumatic dissociation,
level of cognitive performance, and gender on treatment effectiveness will also be considered. We hypothesize that
NET will be more effective than a waitlist condition or TAU in reducing PTSD and other symptoms and improving
resilience, and that these effects will be mediated by changes in traumatic memories and posttraumatic cognitions.
Discussion: The results of this trial will provide evidence for the effectiveness of NET in treating trauma-related
symptoms in immigrant children affected by war. The trial will also generate insights into the complex relationships
between PTSD, memory functions, posttraumatic cognitions and cognitive performance in children, and help guide
the future development and implementation of therapeutic interventions for PTSD in children.
Trial registration: ClinicalTrials.gov NCT02425280. Registered 15 April 2015.
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Background
In 2014, 230 million children lived in countries and areas
affected by armed conflicts [1]. With increasing emigra-
tion and refugeeism, millions of children who have experi-
enced war now also inhabit countries with no active
conflicts. Research confirms high rates of mental health
problems among war-affected children [2], even higher
than those of similarly affected adults [3]. Studies demon-
strate both general dose-effect relationships between ex-
posure to war and trauma-related stress symptoms and
specific types of war experiences that are particularly trau-
matizing [2]. As many as 47 % of children exposed to war
may suffer from posttraumatic stress disorder (PTSD) and
43 % from depression, while reviews and surveys sug-
gest a prevalence of 10–30 % for PTSD among all
refugee and asylum seeking children resettled into
high-income countries [4, 5].
Though most trauma survivors recover with time, for
some, posttraumatic stress symptoms due to war experi-
ences in childhood show persistence for years and even
decades [6, 7], and have been shown to be related to a
number of psychological and physical health issues even
in older age [8]. PTSD in children also appears to be
connected to lower verbal memory function and overall
cognitive performance [9, 10] and is linked to impair-
ment in academic performance [11, 12]. In addition to
the decreased quality of life and increased suffering of
trauma survivors, PTSD carries enormous economic
costs associated with loss of personal income, inability
to work, as well as increased utilization of treatment and
support services. For example, in 2004, the social and
welfare costs of claims for incapacitation and severe dis-
ablement in the UK from severe stress reactions and
PTSD amounted to £104 million per annum [13]. Post-
traumatic stress symptoms in children due to organized
violence are thus a pressing, global problem. Developing
effective, evidence-based interventions to address this
problem should be a public health priority globally.
In this paper, we describe a randomized controlled trial
(RCT) evaluating the effectiveness and potential mecha-
nisms of change of a targeted intervention, Narrative Ex-
posure Therapy, NET [14], for children who suffer from
posttraumatic stress symptoms due to experiences of war
or armed conflict. To our knowledge, it is the first effect-
iveness study of NET as implemented in the context of the
existing healthcare system of a high-income country. In
this context, it is also the first trial to explore whether
changes in the quality of traumatic memories and post-
traumatic cognitions are potential candidates for effective
mechanisms of change in PTSD symptom reduction
among war-affected children in treatment. This study
protocol aims to present all relevant information pertain-
ing to this randomized controlled trial, as set out by the
CONSORT 2010 guidelines [15].
For traumatized children in general, cognitive-behavioral
therapy (CBT) has been repeatedly found to be effective in
reducing PTSD and other symptoms [16–18], and trauma-
focused cognitive-behavioral therapy (TF-CBT) is recom-
mended as the primary treatment for PTSD for both
adults and children in several countries [19,20]. For chil-
dren affected by war specifically, a variety of group and in-
dividual interventions have been implemented and studied
all over the world. Reviews have reported evidence on the
effectiveness of such psychosocial interventions in alleviat-
ing PTSD, depression and anxiety symptoms in children
affected by armed conflict [21–23]. However, reductions in
symptoms have often been modest, and study designs have
lacked rigor, with only a small minority representing RCTs.
The majority of intervention techniques among chil-
dren traumatized by war are also based on CBT and its
derivatives. CBT-based interventions for traumatic stress
share similar creative, narrative, and cognitive elements,
such as creative-expressive exercises (dream work and
fantasy), cognitive restructuring, attention control, body-
oriented methods, building a sense of safety, and provid-
ing psychoeducation. However, it is still largely unclear
which specific treatment elements in these interventions
might be most significant for recovery. Furthermore,
there is a general lack of rationales based on clear theor-
etical frameworks as to which particular CBT tools are
chosen for use in treatment [22]. Therefore, there have
been calls for research on the underlying mechanisms of
change that contribute to the success or otherwise of in-
terventions among war-affected children, i.e., particular
processes mediating their effectiveness [21].
NET as a CBT-based intervention
Narrative Exposure Therapy is a manualized, individual,
short-term intervention program for the treatment of
PTSD resulting from exposure to organized violence or
other repeated traumatic events. NET is based on CBT
principles, with its development influenced by exposure-
based and testimonial therapies [14]. The specific focus
in NET is on habituation to and contextual anchoring of
traumatic memories. This focus stems from the clinical
model of repeated traumatization underlying NET, draw-
ing on 1) dual representation theories of PTSD [24, 25],
see also [26], and 2) Emotional Processing Theory and
the idea of fear networks [27].
According to dual representation theory, during a highly
emotional event, two differing types of parallel memory
representations are encoded. The sensory, cognitive-
emotional and physiological features of the event are
stored in long-term perceptual memory [26], and have
been called hot memories [14, 24], Situationally Accessible
Memories [25] or sensation-near representations [28],
while the contextual, verbalizable elements of the situation
are encoded into episodic memory [26], and have been
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called cold memories [14, 24], Verbally Accessible Memor-
ies [25] or contextualized representations [28].
Based on Emotional Processing Theory, hot memories
are thought to be stored as sensory-perceptual represen-
tational networks, containing memories of stimuli in dif-
ferent modalities, together with cognitive and emotional
states experienced during the event. Such represen-
tational networks may be created for any emotionally
significant event. However, in the case of a traumatic
event, the generated representation (called a fear net-
work) would be unusually expansive and contain a great
number of sensory, cognitive, emotional and physio-
logical elements, most of which were previously consid-
ered safe and non-threatening. The large number of
such elements and the strong connections formed be-
tween them mean that activation of just one element in
the network may be enough to activate the entire struc-
ture. As the activation of the network (such as, in the
form of a flashback) is a frightening event, this leads to
trauma survivors avoiding any elements included in the
network, as well as any possible cues reminding them of
these elements. This understanding of the disconnected
encoding of sensory-perceptual memories accounts for
the avoidance, intrusion and numbing (avoiding even posi-
tive emotional experiences) symptoms seen in PTSD.
Cold memories, for their part, are seen to be selective
representations of the contextual and factual elements of
the event, consciously and verbally accessible to the
trauma survivor. For a single event, a fear network usually
remains mostly connected to its cold memory counter-
part, and some autobiographical context is maintained.
However, if a new traumatic experience becomes inte-
grated into an already existing fear network of previous
traumatic experiences, this connection may be partly or
wholly lost. Thus, with each additional traumatic event,
the fear network grows, and the hot memories become in-
creasingly disconnected from the contextual referents of
the cold memories (such as time and place). Hence, with
repeated traumatization, the resulting fear/trauma net-
work may end up containing sensory elements and
disconnected perceptual or physiological memories from
many traumatic events, all mixed together with little
spatio-temporal context.
Based on this clinical model of PTSD, the central treat-
ment element in NET is activating sensory-perceptual
representations of traumatic events, especially the most
intensely emotional and most autobiographically fragmen-
ted ones, and reconnecting them to the contextual epi-
sodic memories of the events in question. In other words,
NET aims to provide a distinct time and place for the dis-
organized, highly emotional memories trauma survivors
have of their experiences.
As most survivors of organized violence have experi-
enced a number of traumatic events, it is often difficult
or impossible for them to identify a single worst event to
be processed by traditional pure exposure methods. To
address this difficulty, NET treatment begins by the par-
ticipant constructing a representation of his whole life
from early childhood up to the present, placing import-
ant events, both positive and traumatic, on a lifeline. All
traumatic events identified in this manner are then nar-
rated in chronological order. The trauma survivor is
thus exposed to repeated and detailed elaboration of
what happened during the traumatic events and may be-
come desensitized to trauma reminders. Subsequently,
physical and psychological hyperarousal and the need to
avoid painful reminders should decrease. At the same
time, survivors are assisted in integrating their con-
scious, verbally accessible memories and thoughts with
sensory-based traumatic memories into coherent, emo-
tionally versatile and meaningful stories of these import-
ant moments in their lives. Creating this trauma
narrative and processing the trauma emotionally and
cognitively contributes to the integration of the trauma
and its meaning into an optimal self-concept and life
history [14] and to the disconfirmation of maladaptive
beliefs or appraisals that may have developed after the
trauma.
Previous research on NET
A review of five RCTs conducted on NET with adults
concluded that good evidence already exists to support
the use of NET in the treatment of PTSD among adult
survivors of organized violence [29]. Promising evidence
from three randomized trials is already available with
children as well [5, 30, 31], reviewed in [29]. For refugee
children in a high-income country (Germany), NET lead
to reductions in symptom severity in all PTSD symptom
clusters at 4 weeks post-treatment, sustained for 12 months,
while there were no significant changes in a waiting list
condition [5]. Among former child soldiers in Uganda,
some of whom were adolescents and some young adults,
NET reduced PTSD symptoms significantly more than ei-
ther a program of academic catch-up and supportive coun-
selling or a waiting list condition, with significant changes
in PTSD symptom scores in 20 out of 25 participants in
the NET group [31]. Further, Catani et al. found NET treat-
ment to be at least as effective as a meditation-relaxation
protocol in reducing PTSD symptoms and functional im-
pairment in 8–14-year-old Sri Lankan children affected by
both war and a very recent mass disaster (tsunami), though
comparison to spontaneous recovery was not possible in
these conditions [30].
Current trial
The general objective of this study is to contribute to
the search for the most effective, evidence-based inter-
vention methods to help children traumatized by war.
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The study aims to achieve this objective by comparing the
effectiveness of NET in the treatment of war-affected chil-
dren suffering from posttraumatic stress reactions with
both a waiting list condition and a treatment as usual
(TAU) control condition in a parallel-group randomized
controlled trial. In addition, the potential mediating and
moderating effects of a number of factors related to mem-
ory and other cognitive processes will be explored. The
trial is pragmatic by nature, being carried out inside the
Finnish healthcare system and emphasizing direct applic-
ability of its results to that system and others similar to it.
This trial aims to extend the evidence from previous
RCTs [5, 30, 31] on the effects of NET on children’s psy-
chopathology in at least six different ways.
First, in comparison to earlier studies carried out on
NET with children, this trial benefits from a compara-
tively large and inclusive sample drawn from immigrant
children settled or seeking to settle in Finland. Only one
study has previously studied the use of NET with refu-
gee or immigrant children in their new home country,
with no active control group [5].
Second, all previous studies on NET with children up
to 2014 have involved one or more of the developers of
NET in some position. This trial will be carried out by
independent researchers with no affiliation to the insti-
tutions involved in the development of NET.
Third, whereas much of the earlier research on NET
may be more accurately described as efficacy studies,
this trial is one concerned with effectiveness in a current
real-world clinical framework. Thus, it tends towards the
pragmatic end of the pragmatic-explanatory continuum,
in the sense defined by the extension of the CONSORT
statement on pragmatic trials [32]. It is to our know-
ledge the first such pragmatic effectiveness study on
NET with children carried out in a high-income setting.
The setting in question is the existing Finnish health-
care system, mostly in the Tampere region, including
three outpatient clinics and two in-patient psychiatric
wards. The clinicians carrying out the intervention and
acting as assessors are healthcare professionals who
would in any case treat these children, mostly psychol-
ogists, psychiatrists and psychiatric nurses, some with
formal psychotherapy training. The pragmatic nature of
the trial adds to its practical significance, as a new
treatment method and targeted intervention will be
rolled out in the context of the Finnish healthcare
system.
Fourth, going beyond studying the simple effectiveness
of NET, this trial aims at improving our understanding
of the process of healing and recovery from posttrau-
matic stress symptoms due to war exposure. The trial
does this by analysing some of the mechanisms of
change that the theory underlying NET suggests would
contribute to its success or otherwise.
Based on that theory, we expect that the effects NET has
on posttraumatic stress symptoms would occur through
recontextualizing disconnected sensory-perceptual mem-
ories, and linking them with their verbalizable episodic
memory counterparts. This process would result in and be
evinced by less fragmented memories of traumatic events
with more spatial and temporal contextualization and co-
herence. Such memories would also be less vivid, biased,
and intrusive and would include more verbal and fewer
sensory elements.
In addition to changes in memories of traumatic events,
this study considers improvements in dysfunctional, overly
negative appraisals of the trauma and its sequelae [33] as
potential mechanisms of change. The theory underlying
NET [27] would suggest that symptom reduction in PTSD
via exposure methods might also be achieved through re-
ductions in such dysfunctional cognitions related to the
trauma. Some evidence already exists of the involvement
of dysfunctional trauma-related cognitions in the mainten-
ance of PTSD symptoms in children [34, 35], as well as for
changes in trauma-related cognitions predicting PTSD
symptom reduction in adults undergoing prolonged ex-
posure [36] and cognitive processing therapy [37].
Fifth, by including a wide range of children without
strict exclusion criteria and collecting a wide range of
biographical information on these children together with
information on peri-traumatic dissociation and cognitive
performance, the trial also aims to explore factors pos-
sibly limiting the effectiveness of NET. At the same time,
it may be possible to identify groups of traumatized chil-
dren for whom NET is a particularly useful and effective
treatment. Including analyses of potential moderators in
RCTs has been recommended to reveal possible hetero-
geneity of effect sizes within samples and to avoid over-
generalization of study results [38].
The effects of significant dissociation on the effectiveness
of PTSD treatments, especially with children, is still an
open question. One trauma intervention among Palestinian
children significantly reduced the proportion of clinical
posttraumatic stress symptoms only among girls who had a
low level of peritraumatic dissociation [39]. On the other
hand, for NET in particular, levels of derealization and
depersonalization were not found to moderate treatment
outcomes with adult refugees in Norway [40]. As regards
cognitive performance, Aupperle, Melrose, Stein, and
Paulus have presented a model on how cognitive im-
pairments may contribute to the clinical profile of
PTSD and lead to the use of alternative coping styles
such as avoidance [41]. In light of this possibility, we
will also study whether the effects of NET differ ac-
cording to the children’s level of cognitive performance.
Finally, we study the effects of NET treatment, as com-
pared to a waiting list and TAU, on a number of other out-
come variables in addition to PTSD symptom levels. From
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a practical perspective, the effects of the intervention on de-
pressive symptoms, overall psychological distress as well as
resilience and cognitive performance are relevant indicators
of clinical effectiveness and impact.
Taking into account the very high levels of comorbid de-
pression in children with PTSD [42], examining whether
NET, though targeted at PTSD symptoms, might also re-
duce depressive symptoms is an important goal. Previous
research on prolonged exposure therapy has found that
successful treatment of PTSD symptoms lead to reduc-
tions in depressive symptoms as well, both in female
adults [43] and children [44].
Very few studies have assessed the effects of PTSD
treatment on cognitive performance, and there have
been calls for more such research [41]. For that reason
we also explore possible deficits in attention, working
memory, executive functioning and general cognitive
performance, their relationship to levels of PTSD symp-
toms and traumatic exposure, as well as the effects of
NET on such deficits, in a subsample of participants. Re-
views suggest that in adults some cognitive impairment,
at least impaired executive functioning and attention, is
associated with PTSD symptoms, as separated from the
effects of exposure to trauma per se [45, 46]. However,
twin studies of combat-exposed adults suggest this may
be at least partly due to higher pre-trauma cognitive
capacity acting as a protective factor promoting resili-
ence in the face of traumatic experiences [47].
Research questions and hypotheses
This study will address the effectiveness of NET in treating
trauma-related symptoms and improving resilience and
cognitive performance. The mediating roles of trauma-
related cognitive appraisals and memory functions on this
effectiveness will also be studied, as well as several mo-
derators potentially affecting recovery. Accordingly, the re-
search questions are as follows.
1. Does NET reduce a) posttraumatic stress disorder
symptoms, b) depressive symptoms and/or
c) psychological distress symptoms in children
traumatized by war more effectively than a waiting
list condition or treatment as usual? Does NET
increase resilience or improve cognitive performance?
The hypothesis is that NET is more effective in
reducing PTSD, depressive and psychological
distress symptoms as well as in increasing resilience
and improving cognitive performance than TAU or
a waiting list condition, to a statistically and
clinically significant degree.
2. What changes in the participants’ trauma-related
memory functions and cognitions can be observed
as a result of NET treatment, as compared to a
waiting list condition and treatment as usual?
The hypotheses are that statistically significant
differences between the NET group and the control
groups will be found in the participants’ trauma-
related memory functions and cognitions at the end
of treatment. It is hypothesized that at the end of
treatment, NET participants will show lower levels
of overgeneralization and fragmentation in their
autobiographical memories, as compared to baseline,
as well as more spatial and temporal contextualization
and coherence. The trauma memories of children
after NET are expected to be less biased and intrusive
as compared to controls, and include more verbal and
fewer sensory elements. Finally, it is hypothesized that
participants in the NET group exhibit greater
reductions in dysfunctional trauma-related
cognitive appraisals, as compared to the waiting
list and TAU groups.
3. To what extent do these changes in trauma-related
memory functions and cognitions mediate the
effectiveness of NET in reducing PTSD symptoms,
depressive symptoms and psychological distress
symptoms, increasing resilience and improving
cognitive performance?
The hypothesis is that beneficial changes in
autobiographical memory, trauma-related memories
and trauma-related cognitive appraisals partly explain
the reduction in at least PTSD and depressive
symptoms among children who participate in NET,
and may contribute to increased resilience and
improved cognitive performance.
4. To what extent does level of peritraumatic dissociation,
level of cognitive performance or gender moderate the
effectiveness of NET in reducing trauma-related
symptoms?
The hypothesis is that participants with very high
levels of peritraumatic dissociation benefit less from
the intervention in terms of symptom reduction.
Girls and children with higher levels of cognitive
performance are hypothesized to benefit more from
the intervention.
Methods/Design
Trial design
We are conducting a multicenter, parallel-group, ran-
domized, controlled trial comparing NET to a waiting
list condition and TAU at several treatment units located
in Finland. Five sets of assessments will be carried out:
baseline, T0 (3 months before the start of treatment);
pre-test, T1 (when treatment begins); during treatment,
T2 (approximately halfway through the treatment); post-
test, T3; and follow-up, T4 (three months after treat-
ment). A three-month follow-up period is considered
long enough to assess medium-term maintenance of
treatment gains, but still short enough to be practically
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implementable in this context, where drop-outs due to,
e.g., asylum seekers being denied asylum and leaving the
country, are possible. A three-month follow-up period
also means that the T0, T1, T3 and T4 measurements
are conducted at equal intervals of three months. Table 1
presents the measurements taken at each point of
assessment.
There are two control conditions. First, the time
each child spends waiting for treatment to begin, typ-
ically three months, will be considered a waiting list
control condition. Second, each participant will be
randomized into one of two groups. One group will
receive NET, acting as the study group, and the other
group, receiving TAU, will act as a positive-control
group. The trial is parallel-group in nature, with a ran-
domized block design with varying block sizes and an
allocation ratio of 1:1.
Study locations
Most of the interventions will be carried out at three co-
operating outpatient clinics and two inpatient wards, all
places where traumatized children of immigrant back-
ground would in any case receive treatment. These clinics
and wards are 1) the Family Counselling Centre of the City
of Tampere, 2) the Psychiatric Clinic for Traumatized
Children at Tampere University Hospital, 3) the Adolescent
Psychiatry Clinic at Tampere University Hospital, 4) the
Psychiatric Treatment and Research Unit for Adolescent
Intensive Care (EVA) at Tampere University Hospital, and
5) the Centre for Torture Survivors (Helsinki Deaconess
Institute). In addition, some participants may be recruited
by and receive treatment from co-operating individual ther-
apists operating privately.
Planned interventions
Figure 1 shows the flow diagram of experimental vs.
control situations in the study design.
NET intervention
For the intervention group receiving Narrative Exposure
Therapy treatment, the intervention will last for approxi-
mately three months and include 10–12 weekly sessions
of 60–90 min. The course of the intervention will follow
the NET manual [14].
The NET intervention begins with a clinical assessment
(partly already collected during the T0 measurement), col-
lecting demographic data, and assessing current com-
plaints. This pre-treatment diagnostic session is followed
by a session of psychoeducation, which includes explain-
ing the child’s current condition to him/her in a way that
helps her/him understand the diagnosis and the purpose
of the treatment. After diagnosis and psychoeducation, the
narrative exposure portion of the intervention begins.
During the first narrative session, the child and the therap-
ist construct a lifeline for the child, with a rope/string
representing his/her life from birth up to the present.
Next, flowers and stones are placed on the lifeline at
chronologically corresponding locations to represent
happy moments in life and difficult, fearful or painful mo-
ments, respectively. Other symbolic elements may also be
used for other significant life events.
The following sessions are generally each devoted to
processing a single traumatic event through narrative ex-
posure. Thus, the number of narrative sessions depends
on the number of events identified on the lifeline, but
should generally be limited to 6–9 weekly sessions. The
chronology of the narration during the intervention
Table 1 Points of assessment and measures used
T0 Baseline T1 Pre-test T2 Midpoint T3 Post-test T4 Follow-up
Approx. three months before
start of treatment
At start of
treatment
Approx. halfway through
treatment
Immediately after
treatment
Three months after
treatment
– CRIES – CRIES – CRIES – CRIES – CRIES
– DSRS – DSRS – C-PTCI – DSRS – DSRS
– SDQ – SDQ – TMQQ – SDQ – SDQ
– C-PTCI – C-PTCI – SUDS (each session) – C-PTCI – C-PTCI
– CYRM – CYRM – TMQQ – TMQQ
– TMQQ – TMQQ – CYRM – CYRM
– PDEQ – CSRS – CSRS
For subsample: For subsample:
– WMTB-C – WMTB-C
– RPM – RPM
– TMT – TMT
C-PTCI, Children’s Post-Traumatic Cognitions Inventory; CRIES, Children’s Revised Impact of Event Scale; CSRS, Child Session Rating Scale; CYRM, Child and Youth
Resilience Measure; DSRS, Depression Self-Rating Scale for Children; PDEQ, Peritraumatic Dissociative Experiences Questionnaire; RPM, Raven’s Progressive Matrices;
SDQ, Strengths and Difficulties Questionnaire; SUDS, Subjective Units of Distress Scale; TMT, Trail Making Test; TMQQ, Trauma Memory Quality Questionnaire;
WMTB-C, Working Memory Test Battery for Children
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follows the lifeline, addressing all traumatic incidents
throughout the course of the child’s biography, accom-
panied by other turning points in her/his life. In each
session, the therapist writes down the child’s narration.
In the subsequent session, the narrative from the previ-
ous session is read aloud to the child, and the child is
asked to correct it or add any details that may have been
missed. The procedure is repeated in subsequent ses-
sions until a final version of the child’s biography is cre-
ated. In the last session, the biography as a whole is read
aloud to the child. The child and the therapist sign the
written narration. One copy is handed to the child. An-
other is kept for research purposes, provided that per-
mission for this is obtained.
All clinicians providing treatment will receive a three-
day training on NET by instructors experienced in the
method. Each participating unit will be provided with
NET manuals. For the NET intervention group, clini-
cians are instructed to adhere as strictly as possible to
the intervention as laid out in the NET manual. Semi-
annual supervisory meetings will be organized with the
clinicians and the research team to discuss the use of
Fig. 1 Adapted CONSORT flow diagram. Adapted CONSORT flow diagram, illustrating the study design, the flow of participants in the study and
the planned assessments
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the treatment method and any issues in implementing it
that may have appeared. The developers of the method
are also available for supervisory purposes via Skype.
Control intervention
For the TAU control group, participants will receive the
usual care for posttraumatic stress symptoms currently
offered by each unit. This treatment may last for more
than the three months the NET intervention will take,
but T3 measurements will in any case be collected three
months after treatment has started. No specific instruc-
tions will be given to clinicians as to what TAU should
entail, apart from not including elements specific to
NET. Thus, in keeping with the pragmatic goal of study-
ing the effectiveness of NET as compared to current
usual care, the TAU provided by clinicians at cooperat-
ing units will vary and include whatever methods they
have used until now. These methods are likely to include
the use of (TF-)CBT, Eye Movement Desensitization and
Reprocessing and forms of family therapy. Information
about the kind of treatment offered to each participant
in the control group will be collected.
Participants
The participants of the study are up to 80 children (be-
tween 9 and 17 years of age) living in Finland who will
attend Narrative Exposure Therapy or treatment as usual
for posttraumatic stress symptoms due to exposure to
armed conflict. As no war or major organized violence
has taken place in Finland for decades, these participants
will be immigrants, refugees or asylum seekers. The
sample will be collected among all eligible children who
are clients of (a) The Family Counselling Center of the
City of Tampere, (b) The Psychiatric Clinic for Trauma-
tized Children at Tampere University Hospital, c) The
Adolescent Psychiatry Clinic at Tampere University Hos-
pital, d) the Psychiatric Treatment and Research Unit for
Adolescent Intensive Care at Tampere University Hospital,
e) The Centre for Torture Survivors of the Helsinki
Deaconess Institute or f) co-operating individual private
practitioners trained in NET.
Inclusion and exclusion criteria
Inclusion and exclusion criteria applied to clinical re-
search on PTSD vary widely, with no established stan-
dards [48]. In keeping with the aim of carrying out a
pragmatic trial in usual care settings, this trial aims for a
great variety of participants with few exclusion criteria.
Thus, only acute psychosis or marked intellectual dis-
ability will be considered definite criteria for exclusion,
while other comorbid conditions such as depression,
generalized anxiety disorder or obsessive-compulsive
disorder will not. Generally, any child between 9–17
years old who a) has spent some part of her/his life
living in a country where organized violence was taking
place, or at a refugee camp, and b) suffers from signifi-
cant stress symptoms thought be trauma-related, may be
included in the study. All children will be clinically
assessed at the start of treatment, but a formal diagnosis
of PTSD is not required.
Measures
Primary outcomes
Posttraumatic stress symptoms will be measured at T0,
T1, T2, T3, and T4, employing the children’s version of
the Revised Impact of Event Scale (CRIES) [49]. CRIES
consists of 13 items covering the re-experiencing, avoid-
ance and hyperarousal symptom dimensions. Children
estimate the occurrence of each symptom on a 4-point
scale. CRIES-R has been found to have good reliability
among war-affected children [50].
Depressive symptoms will be measured at T0, T1, T3,
and T4 employing the Depression Self-Rating Scale for
Children (DSRS) [51]. The measure includes 18 items
that assess the cognitive, affective, and behavioral di-
mensions of depression. At each item, children estimate
on a 3-point scale whether they have experienced the
symptom over the preceding two weeks.
Psychological distress will be measured at T0, T1, T3,
and T4 employing the Strengths and Difficulties Ques-
tionnaire (SDQ) [52]. One form is provided for self-
assessment by the child and another for a parent or
guardian, if available. The measure covers emotional and
behavioral problems and hyperactivity. Each dimension
consists of 5 items evaluated on a 3-point scale as to
how well the description fits the situation of the child.
Resilience will be measured at T0, T1, T3, and T4
using an adapted, focus-group-based version of the
Child and Youth Resilience Measure (CYRM) (28-item
version originally developed by Ungar and Liebenberg
[53], and validated in [54]). CYRM is a questionnaire ex-
ploring the individual, relational, communal and cultural
resources that may bolster the resilience of 9–23-year-
old youth. The participant reports on a 5-point scale as
to what extent he/she feels he/she has certain resources.
Cognitive performance (of a subset of participants)
will be addressed by measuring a) attention and work-
ing memory, b) non-verbal, general cognitive per-
formance and c) executive functioning. Attention and
working memory will be measured at T0 and T4
employing performance-based sub-tests for verbal and
spatial working memory from the Working Memory
Test Battery for Children (WMTB-C) [55]. Non-verbal,
general cognitive performance will be assessed at T0
and T4 employing age-appropriate versions of Raven’s
Progressive Matrices (RPM) [56]. Executive functioning
will be measured at T0 and T4 employing the Trail
Making Test (TMT) [57].
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Secondary outcomes and mediators
Quality of traumatic memory will be assessed at T0, T1,
T2, T3, and T4 employing the Trauma Memory Quality
Questionnaire (TMQQ) [58]. The measure contains 11
items related to the visual quality, non-visual sensory
qualities (e.g., auditory, olfactory and proprioceptive sen-
sations), and temporal context of the traumatic memory,
as well as to the extent to which the memory is in a ver-
bally accessible format. Participants evaluate each item
on a 4-point scale as to how much they agree with the
statements.
Trauma-related cognitions are measured at T0, T1,
T2, T3, and T4 using the Children’s Post Traumatic Cog-
nitions Inventory (C-PTCI) [59]. The measure includes 25
statements on the kinds of thoughts and feelings the child
has had after the traumatic event, e.g., “I feel like I am a
different person since the frightening event.” Children
evaluate on a 3-point scale how well the descriptions fit
them.
General functioning of autobiographical memory will
be explored, in the intervention group only, by tracking
the number of life events initially identified at the start
of the intervention, as well as the recovery of new events
and possible temporal reorganization of life events dur-
ing therapy. In addition, the written life narratives that
result from NET treatment will be coded for (1) emo-
tional tone (positive vs. negative), (2) thematic lines
(agency and communion), and (3) narrative complexity
[60], as well as for sequences of redemption and con-
tamination [61].
Additional measures: moderators and measures related to
therapeutic interaction
Peritraumatic dissociation will be assessed at T0 using
the Peritraumatic Dissociative Experiences Questionnaire
(PDEQ) [62]. The measure assesses the level of dissoci-
ation at the time of the traumatic event and immediately
after it. 10 items are evaluated on a scale from 1 (not
true at all) to 5 (extremely true).
Cognitive performance at T0, measured as described
above, will also be treated as a possible moderator.
Distress during the therapeutic intervention is mea-
sured several times during each treatment session using
the Subjective Units of Distress Scale (SUDS) [63]. The
level of distress is measured in order to guarantee the
safety of the intervention as well as to obtain data on
the intrusiveness of narratives. SUDS consists of a
thermometer-like scale from 0 to 10 that measures the
subjective intensity of disturbance or distress currently
experienced by the participant. When prompted, the
child points to or otherwise indicates where he/she is at
on the scale at the moment. SUDS is commonly used as
a benchmark for a professional or observer to evaluate
the progress of treatment.
Intervention effectiveness and effective treatment com-
ponents from the client’s point of view are assessed with
the Child Session Rating Scale (CSRS) [64], administered
at T3. In the CSRS, the child evaluates five dimensions
of interaction during the intervention by marking a
point on a line segment.
Procedure
A sequential procedure will be applied to data collection.
Whenever a child is identified as a potential participant
by a clinician at one of the co-operating units, informa-
tion concerning the intervention and the related re-
search is provided both to the participant him/herself
and to his/her parents. If they are willing to participate
in the research, informed consent will be requested from
the child and his/her parents.
Waiting list control baseline data (T0) will be collected
during this first meeting with the clinician. The children
will then be randomly assigned to EITHER the ‘treat-
ment as usual’ group (n = 40) OR the ‘NET intervention’
group (n = 40). Because of the treatment queues cur-
rently present at most of the treatment units, all partici-
pants will first be placed under waiting-list conditions
for approximately three months (waiting list control
condition, n = 80). In the unlikely case that there is no
treatment queue at the moment, the participant will
begin NET or TAU immediately and will not contribute
waiting list control data.
At the start of the intervention or TAU, pre-test (T1)
data will be collected from all participants. The T1 data
will serve as an end measurement for the waiting list
control condition and as the pre-test measurement for
the NET intervention and the TAU control condition.
Data (T2) will also be collected once during the treat-
ment for both the NET and the TAU groups. This will
allow for proper analysis of mediating mechanisms. In the
NET group, this assessment will take place at the time
when the worst traumatic memories have been narrated.
Post-test data (T3) will be collected from participants
in both groups, immediately after the intervention for
the NET group, and after three months of treatment for
the TAU group, and follow-up data (T4) will be collected
during a joint family meeting, three months later.
In most cases, the clinician working as the therapist
will also act as the assessor and collect data from the pa-
tients he/she is treating. In some cases, members of the
research team may carry out some assessments, parti-
cularly for follow-up. Interpreters are used whenever
needed during assessments, and will be present during
all assessment and treatment sessions for children who
are not fluent in Finnish.
The procedure will be continued until the sample size
reaches the goal of n = 80, with data collection estimated
to finish during 2017.
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Due to restrictions on the use of the tests used for
measurements of cognitive performance, these add-
itional assessments will be carried out by a member of
the research team (SK), a licensed clinical psychologist,
and studied in a smaller subsample. For n = 20 partici-
pating children about to start treatment during 2015,
willingness and informed consent to participate in these
additional tests will be requested, and the measurements
will then be carried out at T0 and T4 for this subsample.
Sample size calculation
The sample size was calculated using G*Power 3.1.9.2
[65]. Earlier results obtained on NET with children
[5, 31] suggest large between-groups effect sizes of d =
0.7–1.0 for PTSD symptom severity for NET vs. waiting
list. For determining the effectiveness of NET vs. waiting
list, with α = 0.05, d = 0.85 (f ≈ 0.40) and a priori test
power = 0.80 (β = 0.20), 52 participants would be re-
quired for analyses of covariance of fixed effects, main
effects and interactions on primary outcomes.
There are no effect size estimations available for TAU as
offered to traumatized children at participating clinics, nor
could such estimations be reliably made, taking into ac-
count the diverse nature of TAU expected. However, at
least some effectiveness for TAU over a waiting list can be
assumed. Thus, in order to tease out differences in NET
vs. TAU between-treatments comparisons, we needed to
aim for a sample size that is somewhat larger than that re-
quired for detecting NET vs. waiting list between-groups
differences. At the same time, dropout rates for participa-
tion in NET reported in earlier studies are generally very
low [29, 66], so little attrition is expected. In light of these
considerations and practical limitations, we aim for a sam-
ple of 80 participants.
Randomization
To continuously provide close to equal numbers of par-
ticipants in the control and treatment groups for interim
analysis, random allocation is performed using a ran-
domized block design with variable block sizes and an
allocation ratio of 1:1 [67].
At the start of the study, before any participants were
recruited, the participating clinics were provided with
folders by the research group, each containing all the
relevant research material, questionnaires and measure-
ments for one participant. A sealed envelope was placed
by the research team in each folder with a piece of paper
inside. Half of these papers were marked “NET” and the
other half “TAU”. Whenever a suitable participant is
identified at a study location by a clinician and informed
consent is received from her/him and her/his parents or
guardians, the clinician will randomly select a folder for
her/him. The envelope will then be opened and its con-
tent will determine whether the participant receives
NET or TAU. Allocation was concealed by the use of
opaque, sealed envelopes.
Due to most participating clinicians acting both as treat-
ment providers and assessors, blinding them as to the
treatment status of each participant beyond randomization
(after T0) is not possible and will not be attempted. The
participants themselves cannot be blinded to the interven-
tion, as the differences between TAU and NET will make
it obvious to them which group they belong to.
Statistical analyses
Basic analyses
The sample and its characteristics will be analysed
employing descriptive statistical methods. Means, standard
deviations and other basic statistics for all relevant vari-
ables will be calculated for descriptive purposes. Between-
group comparisons at baseline will be performed to test
randomization and assess differences between treatment
and control groups, as well as between participants at dif-
ferent study locations. The internal reliabilities of the in-
struments used will be analysed employing Cronbach’s α.
For all statistical tests, significance levels will be set at α =
0.05, with the Holm-Bonferroni method used to control
family-wise error rates, where appropriate. Multiple im-
putation will be employed in the case of dropouts or other
missing data. Intention-to-treat analyses will be carried
out, so that all participants who are randomized into ei-
ther group will be included in final analyses.
Effect evaluation
The main effect of NET as compared to TAU and the
waiting list control condition on the primary outcomes
of PTSD symptom severity, depressive symptoms, psy-
chological distress, resilience and cognitive performance
will be analysed employing analyses of covariance. Po-
tential confounding factors (age, gender, treating unit)
will be included as covariates. The main effects of NET
as compared to TAU and the waiting list condition on
the secondary outcomes of trauma memory quality and
trauma-related cognitions will be similarly analysed
employing analyses of covariance. For all analyses of co-
variance, effect sizes will be reported as partial η2, with
95 % confidence intervals included.
Moderator and mediator analyses
Analyses of the potential mediating and moderating fac-
tors will be carried out employing methods of condi-
tional process analysis, based on [68, 69]. The end result
will be presented as a process model of the effects of
NET on PTSD and other symptom measures.
Ethical issues
The Regional Ethics Committee of Tampere University
Hospital has approved the study (R14065, 6/2014), deeming
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it ethically acceptable and fulfilling the requirements of the
Finnish Medical Research Act (488/1999) and the corre-
sponding Decree (986/1999).
Age-specific brochures with information about the
study have been prepared for the participating children
and their guardians, and translated into several lan-
guages. Written consent will be requested from both
parents or guardians and the children themselves.
The anonymity of the subjects will be guaranteed by
removing identity information when analyzing the data.
All data with names and identity information will be
destroyed after a period of five years. The data protec-
tion ombudsman has been notified of the data collection
procedures and the formed register of personal data in
line with the Finnish Personal Data Act (523/1999), §10
and §14. The trial has been registered as clinical trial
number NCT02425280 in the ClinicalTrials.gov Protocol
Registration System on 15 April 2015.
Adherence to the treatment paradigm and procedures
will be guaranteed by instructing clinicians to adhere to
the NET manual as strictly as possible and by organizing
semiannual supervisory meetings.
Interim analyses of differences in treatment outcomes
between NET and TAU will be carried out after all mea-
surements are available from the first 20 participants. If,
at this time, NET treatment is found to be performing
worse than TAU to a clinically significant extent, the
trial will be stopped due to ethical concerns.
Discussion
The practical need for trials such as this is evident and
pressing. Millions of children around the world suffer
from posttraumatic stress symptoms due to experiences
of war and organized violence, and providing them with
the most effective forms of evidence-based help is a
crucial, global concern. As of yet, we still have limited
evidence, especially from RCTs, on the effectiveness of
interventions targeted at war-affected children. A stan-
dardized, manualized intervention like NET with wide
applicability has the potential to become a very useful
tool for providing help to such children, both in their
original home countries and as immigrants, refugees or
asylum seekers in other countries. Thus, providing evi-
dence for its effectiveness in a variety of contexts makes
for clinical research of great practical importance.
At the same time, even as CBT-based interventions
seem to be effective in reducing PTSD symptomatology,
we have no comprehensive view based on theory as to
exactly how and in what conditions this happens. As
such, the results of this trial may contribute significantly
to our understanding of the mechanisms of change that
are crucial to successful treatment of PTSD in children.
The theory underlying NET suggests that improved
contextualization of traumatic memories is central to
recovery from PTSD, and thus we expect that improve-
ments in the quality of traumatic memories will mediate
its effectiveness. Results on the possible mediating role
of decreased dysfunctional trauma-related cognitive ap-
praisals in treatment effectiveness, as suggested by re-
cent research [36,37], further contribute to the search
for active mechanisms of change. Exploring the possible
effects of treatment on elements of cognitive functioning
will shed light on the relationships between level of cog-
nitive performance, trauma and PTSD. Although a great
variety of findings on cognitive impairment in PTSD
exist, there is still significant disagreement as to which
of these findings represent pre-trauma susceptibility and
resiliency factors or effects of comorbid conditions and
which toxic effects of trauma or PTSD [45-47].
Further, including exploration of the potential moder-
ating effects of peri-traumatic dissociation, gender and
level of cognitive performance on treatment effectiveness
in this trial adds to its potential to help guide the future
development of intervention methods.
Generalizability of study results
As a pragmatic trial studying real-world effectiveness in
a usual care setting, the contributions of this trial to
assessing the practical usefulness and applicability of
NET in Finland are direct and immediate. As effective-
ness is studied directly in the healthcare system itself,
there will be no need for a separate implementation and
roll-out phase, should NET be found effective and ap-
plicable in this context. In addition, as no extra re-
sources as such will be provided for participating units,
successfully carrying out NET interventions during the
study will be proof of the feasibility of using NET with
current resource and time constraints in these units.
The results of this study will be generalizable to health-
care settings in the Nordic countries and most other high
income countries where therapeutic interventions such as
NET may be provided to immigrant children. The results
will be less generalizable to care environments where
healthcare services are organized in a very dissimilar man-
ner or where significantly less resources are available for
provision of healthcare.
Risks and limitations
Though it is possible for participating children to tem-
porarily experience increased stress and discomfort dur-
ing NET sessions, long-term iatrogenic risks are not
expected in this trial. However, interim analyses will be
carried out to ensure NET is not performing worse than
TAU to a clinically significant extent.
One notable challenge in this trial will be the question
of language. The majority of therapeutic work carried
out in this trial will likely take place with the help of in-
terpreters. Whenever possible, the same interpreter will
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work with the same child in all NET or TAU sessions,
and interpreters will be given instructions to work as
literally as possible. Constant cooperation with the
organization providing interpreters will be maintained
throughout the study to ensure recruitment of inter-
preters who are familiar with trauma and therapeutic
methods in general, as well as with the special require-
ments of the NET method. Results from earlier NET
studies seem to suggest no significant differences in
outcomes between using and not using interpreters [29].
However, especially as we are dealing with a method
placing great emphasis on narration and verbalization,
the use of interpreters may pose a variety of practical
problems and must be considered a possible source of
confounding effects on study results.
Another challenge for the trial is its reliance on mostly
child-evaluated measures. For many of the factors under
study, other forms of reliable measures do not exist. In
addition, as clinicians will act as assessors for the most
part in this trial, the battery of measures and instru-
ments has to be kept relatively simple and manageable
in scope. In any case, for some measures, such as the
qualities of traumatic memories, it can be expected that
self-evaluations by, in particular, the youngest children
taking part will also present potential sources of con-
founding effects.
The varied nature of the treatment-as-usual condition
we are comparing NET to also poses challenges. On one
hand, we have attempted to mitigate this problem by
also including a waiting list condition, and by collecting
information about the kind of TAU offered to each child.
On the other hand, this variety in TAU is to be expected
in a pragmatic framework and is a realistic reflection of
the varied practices currently in use at the participating
treatment units.
Conclusions
In summary, this article has described the rationale and
design of a randomized controlled trial studying the ef-
fectiveness and prospective mechanisms of change of
Narrative Exposure Therapy in the treatment of post-
traumatic stress symptoms in children affected by war or
armed conflict. Overall, the results of this trial will con-
tribute to basic research on PTSD, memory processes
and cognitive functions in children, as well as to applied
research into therapeutic interventions and their devel-
opment. Beyond the specific analyses described in this
article, the data collected will be utilized in further inter-
disciplinary collaboration with researchers from the
fields of political geography and social anthropology. In
this context, qualitative analysis of the life stories result-
ing from NET is under consideration. We also hope to
utilize the results of this study in future international
comparative research, e.g., by exploring the effects of
treatment location (country of origin vs. new home
country) on the effectiveness of NET.
Trial status
The trial started in December 2014 and data collection
is expected to continue until 2017, with continuous par-
ticipant enrolment.
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